Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study.
Aged
Cardiovascular Diseases
/ diagnosis
Diastole
Diet, Healthy
Double-Blind Method
Female
Heart Rate
Humans
Longitudinal Studies
Male
Middle Aged
Myocardium
/ metabolism
Nutritional Status
Nutritive Value
Oxygen Consumption
Paris
Prospective Studies
Protective Factors
Recommended Dietary Allowances
Risk Reduction Behavior
Time Factors
French Health and Nutrition Program
PNNS
arterial stiffness
cutaneous blood flow
endothelial function
heart rate
heart rate variability
Journal
Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
05
2019
accepted:
28
09
2019
entrez:
6
12
2019
pubmed:
6
12
2019
medline:
25
2
2020
Statut:
epublish
Résumé
To investigate whether chronic adherence to the French Nutrition and Health Program (PNNS) guidelines was associated with better cardiovascular health. A study nested within the SU.VI.MAX2 cohort was conducted on participants without cardiovascular risk factors. Long-term adherence to the PNNS guidelines was estimated using validated dietary scores from 2007 and 2012. Individuals who did (PNNS+) and did not (PNNS-) continuously adhere to the PNNS guidelines were included. Applanation tonometry, impedance cardiography, laser doppler flowmetry, heart rate, heart rate variability, endothelial function was used for the assessment of cardiovascular health. A total of 49 subjects (mean age 65.4 ± 5.6 years, 75.5% women) had been included. Those in the PNNS+ group (n=26) were older, had a higher BMI and fat mass than those in the PNNS- group, both groups had similar metabolic parameters. After adjusting for sex, age, and BMI, PNNS+ subjects were found to have a lower heart rate (60.2 ± 8.0 vs 64.3 ± 8.4 beats/min, p=0.042), a lower heart rate × systolic blood pressure product (7166 ± 1323 vs 7788 ± 1680 beats× mmHg/min, p = 0.009), a longer diastole duration (66.7 ± 3.1% vs 64.6 ± 4.1% of the cardiac cycle duration, p=0.049), and a shorter tension-time index (2145 ± 489 vs 2307 ± 428 ms * mmHg, p=0.018) compared to the PNNS- group. Long-term adherence to the PNNS guidelines had a favorable impact on heart rate, diastole duration, and myocardial oxygen consumption. NCT01579409.
Sections du résumé
BACKGROUND
BACKGROUND
To investigate whether chronic adherence to the French Nutrition and Health Program (PNNS) guidelines was associated with better cardiovascular health.
METHODS
METHODS
A study nested within the SU.VI.MAX2 cohort was conducted on participants without cardiovascular risk factors. Long-term adherence to the PNNS guidelines was estimated using validated dietary scores from 2007 and 2012. Individuals who did (PNNS+) and did not (PNNS-) continuously adhere to the PNNS guidelines were included. Applanation tonometry, impedance cardiography, laser doppler flowmetry, heart rate, heart rate variability, endothelial function was used for the assessment of cardiovascular health.
RESULTS
RESULTS
A total of 49 subjects (mean age 65.4 ± 5.6 years, 75.5% women) had been included. Those in the PNNS+ group (n=26) were older, had a higher BMI and fat mass than those in the PNNS- group, both groups had similar metabolic parameters. After adjusting for sex, age, and BMI, PNNS+ subjects were found to have a lower heart rate (60.2 ± 8.0 vs 64.3 ± 8.4 beats/min, p=0.042), a lower heart rate × systolic blood pressure product (7166 ± 1323 vs 7788 ± 1680 beats× mmHg/min, p = 0.009), a longer diastole duration (66.7 ± 3.1% vs 64.6 ± 4.1% of the cardiac cycle duration, p=0.049), and a shorter tension-time index (2145 ± 489 vs 2307 ± 428 ms * mmHg, p=0.018) compared to the PNNS- group.
CONCLUSION
CONCLUSIONS
Long-term adherence to the PNNS guidelines had a favorable impact on heart rate, diastole duration, and myocardial oxygen consumption.
CLINICAL TRIAL REGISTRATION NUMBER
BACKGROUND
NCT01579409.
Identifiants
pubmed: 31802880
doi: 10.2147/VHRM.S215795
pii: 215795
pmc: PMC6826965
doi:
Banques de données
ClinicalTrials.gov
['NCT01579409']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-475Informations de copyright
© 2019 Fysekidis et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Am Coll Cardiol. 1993 Dec;22(7):1881-6
pubmed: 8245343
Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):718-24
pubmed: 20431391
Handb Exp Pharmacol. 2012;(209):277-94
pubmed: 22249819
Microvasc Res. 2018 Mar;116:6-14
pubmed: 28954218
PLoS One. 2016 Aug 10;11(8):e0159252
pubmed: 27509006
Clin Nutr. 2010 Oct;29(5):678-81
pubmed: 20199827
Cardiovasc Res. 2009 Oct 1;84(1):24-32
pubmed: 19586943
N Engl J Med. 2019 Jan 3;380(1):11-22
pubmed: 30415628
Int J Cardiol. 2014 Feb 1;171(2):299-301
pubmed: 24369792
Eur J Prev Cardiol. 2014 Apr;21(4):521-7
pubmed: 23144202
Br J Nutr. 2011 Mar;105(6):902-10
pubmed: 21251337
Cell. 2016 Jun 30;166(1):209-21
pubmed: 27238020
Am J Clin Nutr. 2018 Jul 1;108(1):136-155
pubmed: 29931038
Am Heart J. 1987 Jun;113(6):1489-94
pubmed: 3591616
Am J Clin Nutr. 2002 Jul;76(1):266S-73S
pubmed: 12081850
Am J Clin Nutr. 1988 Sep;48(3):552-9
pubmed: 3414570
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1485-91
pubmed: 15217803
J Am Diet Assoc. 2009 Jun;109(6):1031-41
pubmed: 19465185
Circulation. 2010 Dec 14;122(24):2521-8
pubmed: 21126970
N Engl J Med. 2005 May 12;352(19):1951-8
pubmed: 15888695
Circulation. 1974 Dec;50(6):1179-89
pubmed: 4430113
Int J Obes (Lond). 2012 Nov;36(11):1455-62
pubmed: 22249228
J Nutr. 1997 Jul;127(7):1422-7
pubmed: 9202101
Arch Intern Med. 2004 Nov 22;164(21):2335-42
pubmed: 15557412
Circulation. 1997 Jul 1;96(1):308-15
pubmed: 9236450
Int J Mol Sci. 2018 Dec 11;19(12):
pubmed: 30544955
Int J Epidemiol. 2000 Aug;29(4):655-60
pubmed: 10922341
Am J Clin Nutr. 2011 Jan;93(1):200-10
pubmed: 21106918
Circulation. 2005 Jan 25;111(3):363-8
pubmed: 15668353
Nutr Metab Cardiovasc Dis. 2015 Nov;25(11):1041-9
pubmed: 26474725
Curr Hypertens Rep. 2013 Jun;15(3):253-9
pubmed: 23645136
Circulation. 2003 Jan 28;107(3):429-36
pubmed: 12551867
Circulation. 1997 Nov 18;96(10):3266-8
pubmed: 9396413
Hypertens Res. 2010 Apr;33(4):293-7
pubmed: 20075933
BMC Public Health. 2013 May 06;13:449
pubmed: 23648225
Hum Nutr Clin Nutr. 1985;39 Suppl 1:5-41
pubmed: 4044297
Eur Heart J. 2010 Mar;31(5):552-60
pubmed: 19793769
Kidney Int. 2003 May;63(5):1852-60
pubmed: 12675863
Diabetes Metab Res Rev. 2011 Oct;27(7):654-64
pubmed: 21695761
Cardiol Rev. 2007 Mar-Apr;15(2):62-6
pubmed: 17303992
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H1-H10
pubmed: 27199129
Br J Nutr. 2012 Aug;108(3):492-9
pubmed: 22348439
Circulation. 2003 Oct 28;108(17):2054-9
pubmed: 14581384
J Am Coll Cardiol. 1993 Aug;22(2):514-20
pubmed: 8335823
Clin Physiol Funct Imaging. 2009 Jan;29(1):74-80
pubmed: 19016812
Vasc Med. 2007 Aug;12(3):189-97
pubmed: 17848475
Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):40-4
pubmed: 24241129
J Am Coll Cardiol. 2000 Dec;36(7):2185-91
pubmed: 11127459
JAMA Cardiol. 2018 Mar 1;3(3):200-206
pubmed: 29365021
Circulation. 1998 May 5;97(17):1695-701
pubmed: 9591763
J Mol Cell Cardiol. 1995 Nov;27(11):2507-20
pubmed: 8596201
Br J Nutr. 2007 Feb;97(2):219-31
pubmed: 17298689
Am J Hypertens. 2007 Apr;20(4):392-7
pubmed: 17386345
Br J Nutr. 2005 Dec;94(6):1004-11
pubmed: 16351780
J Am Coll Cardiol. 1994 Aug;24(2):471-6
pubmed: 8034885
Eur Heart J. 2010 Oct;31(19):2338-50
pubmed: 20530030